ADMA Biologics Inc (ADMA)
17.40
-0.50
(-2.79%)
USD |
NASDAQ |
Dec 20, 16:00
17.47
+0.07
(+0.40%)
After-Hours: 20:00
ADMA Biologics Shareholders Equity (Quarterly): 231.89M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Corcept Therapeutics Inc | 638.84M |
| Alnylam Pharmaceuticals Inc | 32.35M |
| Catalyst Pharmaceuticals Inc | 660.94M |
| Sarepta Therapeutics Inc | 1.221B |
| Krystal Biotech Inc | 885.85M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 390.62M |
| Total Liabilities (Quarterly) | 158.73M |
| Debt to Equity Ratio | 0.437 |
| Current Ratio | 7.088 |
| Net Debt Paydown Yield | 0.16% |